Health Care • Hospital/Nursing Management
$10.27 ▲ +0.29
(+2.91%)
MKT CAP: $2.45B • VOL: 4.21M
52W L $8 52W H $17
BKD // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.19B | $3.13B | $3.02B |
| YoY Revenue Growth % | +2.2% | +3.6% | — |
| Gross Profit | $837.5M | $799.3M | — |
| Gross Margin % | 26.2% | 25.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $13.5M | $46.5M | $18.4M |
| Operating Margin % | 0.4% | 1.5% | 0.6% |
| Net Income (GAAP) | -$262.7M | -$201.9M | -$189.0M |
| EBITDA (Normalized) | $174.7M | $207.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $218.0M | $166.2M | $162.9M |
| Capital Expenditures (CapEx) | $201.5M | $201.3M | — |
| Free Cash Flow (FCF) | $16.5M | -$35.1M | $162.9M |
| FCF Margin % | 0.5% | -1.1% | 5.4% |
| Return on Invested Capital (ROIC %) | 0.3% | 0.9% | — |
| Cash & Short-Term Equivalents | $279.1M | $308.9M | — |
| Total Debt (Short + Long Term) | $4.22B | $4.02B | — |
| Total Stockholders' Equity | -$44.8M | $212.5M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BKD.